Andrew P. Degnan

Person

New Haven, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Oxazolidinones as modulators of MGLUR5
- Patent number RE49735
- Issue date Nov 28, 2023
- Bristol-Myers Squibb Company
- Andrew P. Degnan
Information Patent Grant
Compounds useful as inhibitors of helios protein
- Patent number 11,548,870
- Issue date Jan 10, 2023
- Bristol-Myers Squibb Company
- Andrew P. Degnan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isofuranone compounds useful as HPK1 inhibitors
- Patent number 11,166,959
- Issue date Nov 9, 2021
- Bristol-Myers Squibb Company
- Erika M. V. Araujo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
5H-pyrido[3,2-B]indole compounds as anticancer agents
- Patent number 10,174,024
- Issue date Jan 8, 2019
- Bristol-Myers Squibb Company
- Wen-Ching Han
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic compounds as anticancer agents
- Patent number 9,751,879
- Issue date Sep 5, 2017
- Bristol-Myers Squibb Company
- Derek J. Norris
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tricyclic compounds as anticancer agents
- Patent number 9,725,449
- Issue date Aug 8, 2017
- Bristol-Myers Squibb Company
- Derek J. Norris
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted imidazo[1,5-a]pyrazines as CGRP receptor antagonists
- Patent number 9,695,176
- Issue date Jul 4, 2017
- Bristol-Myers Squibb Company
- Andrew P. Degnan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxazolidinones as modulators of mGluR5
- Patent number 9,688,669
- Issue date Jun 27, 2017
- Bristol-Myers Squibb Company
- Andrew P. Degnan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oxazolidinones as modulators of mGluR5
- Patent number 8,691,821
- Issue date Apr 8, 2014
- Bristol-Myers Squibb Company
- Andrew P. Degnan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
NK-1 and serotonin transporter inhibitors
- Patent number 8,383,821
- Issue date Feb 26, 2013
- Bristol-Meyers Squibb Company
- Andrew P. Degnan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted heterocyclic ethers and their use in CNS disorders
- Patent number 8,026,257
- Issue date Sep 27, 2011
- Bristol-Myers Squibb Company
- Andrew P. Degnan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-migraine spirocycles
- Patent number 7,842,808
- Issue date Nov 30, 2010
- Bristol-Myers Squibb Company
- Prasad V. Chaturvedula
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic agents for the treatment of migraine
- Patent number 7,772,244
- Issue date Aug 10, 2010
- Bristol-Myers Squibb Company
- Andrew P. Degnan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted heterocyclic ethers and their use in CNS disorders
- Patent number 7,632,861
- Issue date Dec 15, 2009
- Bristol-Myers Squibb Company
- Joanne J. Bronson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic anti-migraine agents
- Patent number 7,569,578
- Issue date Aug 4, 2009
- Bristol-Meyers Squibb Company
- Guanglin Luo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-migraine treatments
- Patent number 7,314,883
- Issue date Jan 1, 2008
- Bristol-Myers Squibb Company
- Ling Chen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Calcitonin gene related peptide receptor antagonists
- Patent number 7,220,862
- Issue date May 22, 2007
- Bristol-Myers Squibb Company
- Prasad V. Chaturvedula
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Aryloxyalkylamine NK-1/SSRI inhibitors
- Patent number 7,179,926
- Issue date Feb 20, 2007
- Bristol-Myers Squibb Company
- Yazhong Huang
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
IMIDAZO[1,2-A]PYRIDINE AND [1,2,4]TRIAZOLO[1,5-A]PYRIDINE DERIVATIV...
- Publication number 20240067638
- Publication date Feb 29, 2024
- Bristol-Myers Squibb Company
- David S. Yoon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED OXOISOINDOLINE COMPOUNDS FOR THE TREATMENT OF CANCER
- Publication number 20230322803
- Publication date Oct 12, 2023
- Bristol-Myers Squibb Company
- Andrew P. Degnan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS USEFUL AS INHIBITORS OF HELIOS PROTEIN
- Publication number 20210147383
- Publication date May 20, 2021
- Bristol-Myers Squibb Company
- Andrew P. DEGNAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOFURANONE COMPOUNDS USEFUL AS HPK1 INHIBITORS
- Publication number 20200390776
- Publication date Dec 17, 2020
- Bristol-Myers Squibb Company
- Erika M.V. Araujo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
5H-PYRIDO[3,2-B]INDOLE COMPOUNDS AS ANTICANCER AGENTS
- Publication number 20180093983
- Publication date Apr 5, 2018
- Bristol-Mayers Squibb Company
- Wen-Ching HAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED IMIDAZO[1,5-a]PYRAZINES AS CGRP RECEPTOR ANTAGONISTS
- Publication number 20180030057
- Publication date Feb 1, 2018
- Bristol-Myers Squibb Company
- Andrew P. Degnan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS
- Publication number 20160333013
- Publication date Nov 17, 2016
- Bristol-Myers Squibb Company
- Derek J. Norris
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS
- Publication number 20160326173
- Publication date Nov 10, 2016
- Bristol-Myers Squibb Company
- Derek J. Norris
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS
- Publication number 20160318928
- Publication date Nov 3, 2016
- Bristol-Myers Squibb Company
- Derek J. Norris
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OXAZOLIDINONES AS MODULATORS OF MGLUR5
- Publication number 20160237072
- Publication date Aug 18, 2016
- Andrew P. Degnan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS
- Publication number 20160176864
- Publication date Jun 23, 2016
- Bristol-Myers Squibb Company
- Derek J. Norris
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CGRP RECEPTOR ANTAGONISTS
- Publication number 20150274734
- Publication date Oct 1, 2015
- BRISTOL-MYERS SQUIBB COMPANY
- Andrew P. Degnan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Oxazolidinones as Modulators of MGLUR5
- Publication number 20120283264
- Publication date Nov 8, 2012
- Bristol -Myers Squibb Company
- Andrew P. Degnan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NK-1 and Serotonin Transporter Inhibitors
- Publication number 20100087434
- Publication date Apr 8, 2010
- Bristol -Myers Squibb Company
- Andrew P. Degnan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted Heterocyclic Ethers and Their Use in CNS Disorders
- Publication number 20090124613
- Publication date May 14, 2009
- Bristol -Myers Squibb Company
- Joanne J. Bronson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted Heterocyclic Ethers and Their Use in CNS Disorders
- Publication number 20090018132
- Publication date Jan 15, 2009
- Bristol -Myers Squibb Company
- Andrew P. Degnan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted Heterocyclic Ethers and Their Use in CNS Disorders
- Publication number 20090018163
- Publication date Jan 15, 2009
- Bristol -Myers Squibb Company
- William D. Schmitz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NK-1 AND SEROTONIN TRANSPORTER INHIBITORS
- Publication number 20070249607
- Publication date Oct 25, 2007
- Bristol -Myers Squibb Company
- Andrew P. Degnan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-MIGRAINE TREATMENTS
- Publication number 20070232600
- Publication date Oct 4, 2007
- Bristol -Myers Squibb Company
- Ling Chen
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
ANTI-MIGRAINE SPIROCYCLES
- Publication number 20070149503
- Publication date Jun 28, 2007
- Bristol -Myers Squibb Company
- PRASAD V. CHATURVEDULA
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
Aryloxyalkylamine NK-1/SSRI inhibitors
- Publication number 20060020019
- Publication date Jan 26, 2006
- Yazhong Huang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel therapeutic agents for the treatment of migraine
- Publication number 20050215576
- Publication date Sep 29, 2005
- Andrew P. Degnan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterocyclic anti-migraine agents
- Publication number 20050153959
- Publication date Jul 14, 2005
- Guanglin Luo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Calcitonin gene related peptide receptor antagonists
- Publication number 20040204397
- Publication date Oct 14, 2004
- Prasad V. Chaturvedula
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
Calcitonin gene related peptide receptor antagonists
- Publication number 20040063735
- Publication date Apr 1, 2004
- Prasad V. Chaturvedula
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING

Andrew P. Degnan

Person

Patents Grantslast 30 patents

Oxazolidinones as modulators of MGLUR5

Compounds useful as inhibitors of helios protein

Isofuranone compounds useful as HPK1 inhibitors

5H-pyrido[3,2-B]indole compounds as anticancer agents

Tricyclic compounds as anticancer agents

Tricyclic compounds as anticancer agents

Substituted imidazo[1,5-a]pyrazines as CGRP receptor antagonists

Oxazolidinones as modulators of mGluR5

Oxazolidinones as modulators of mGluR5

NK-1 and serotonin transporter inhibitors

Substituted heterocyclic ethers and their use in CNS disorders

Anti-migraine spirocycles

Therapeutic agents for the treatment of migraine

Substituted heterocyclic ethers and their use in CNS disorders

Heterocyclic anti-migraine agents

Anti-migraine treatments

Calcitonin gene related peptide receptor antagonists

Aryloxyalkylamine NK-1/SSRI inhibitors

Patents Applicationslast 30 patents

IMIDAZO[1,2-A]PYRIDINE AND [1,2,4]TRIAZOLO[1,5-A]PYRIDINE DERIVATIV...

SUBSTITUTED OXOISOINDOLINE COMPOUNDS FOR THE TREATMENT OF CANCER

COMPOUNDS USEFUL AS INHIBITORS OF HELIOS PROTEIN

ISOFURANONE COMPOUNDS USEFUL AS HPK1 INHIBITORS

5H-PYRIDO[3,2-B]INDOLE COMPOUNDS AS ANTICANCER AGENTS

SUBSTITUTED IMIDAZO[1,5-a]PYRAZINES AS CGRP RECEPTOR ANTAGONISTS

TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS

NOVEL TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS

TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS

OXAZOLIDINONES AS MODULATORS OF MGLUR5

NOVEL TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS

CGRP RECEPTOR ANTAGONISTS

Oxazolidinones as Modulators of MGLUR5

NK-1 and Serotonin Transporter Inhibitors

Substituted Heterocyclic Ethers and Their Use in CNS Disorders

Substituted Heterocyclic Ethers and Their Use in CNS Disorders

Substituted Heterocyclic Ethers and Their Use in CNS Disorders

NK-1 AND SEROTONIN TRANSPORTER INHIBITORS

ANTI-MIGRAINE TREATMENTS

ANTI-MIGRAINE SPIROCYCLES

Aryloxyalkylamine NK-1/SSRI inhibitors

Novel therapeutic agents for the treatment of migraine

Heterocyclic anti-migraine agents

Calcitonin gene related peptide receptor antagonists

Calcitonin gene related peptide receptor antagonists